News & Updates
Filter by Specialty:
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
In the treatment of patients with mild ischaemic stroke or transient ischaemic attack (TIA), the combination of cinnamon and aspirin outperforms aspirin alone at reducing the risk of 90-day recurrent stroke, as shown in a study.
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
01 Apr 2022
Empagliflozin benefits similar between MRA users, nonusers
In patients with heart failure (HF) and preserved ejection fraction, treatment with empagliflozin delivers comparable benefits in reducing first hospitalization for HF or cardiovascular death (primary outcome) between users and nonusers of mineralocorticoid receptor antagonists (MRA), reports a study.
Empagliflozin benefits similar between MRA users, nonusers
31 Mar 2022
Ebbs and flows in weight influence CVD risk in T2D patients
In individuals with type 2 diabetes (T2D), greater variability in adiposity indices (BMI and waist circumference [WC]) was tied to increased risk of cardiovascular disease (CVD) outcomes and death – but an intensive weight loss programme mitigated this risk, a study suggests.
Ebbs and flows in weight influence CVD risk in T2D patients
31 Mar 2022
Robotic exoskeleton helps with mobilization in patients with heart failure
The use of a robotic exoskeleton is a feasible intervention to assist mobilization in patients with advanced heart failure, according to a recent study.
Robotic exoskeleton helps with mobilization in patients with heart failure
31 Mar 2022
Low-dose aspirin prevents common GI cancers in Chinese adults without ASCVD
Low-dose aspirin reduces risks of some common gastrointestinal (GI) cancers, including colorectal cancer (CRC) and gastric cancer (GC), in Chinese without atherosclerotic cardiovascular disease (ASCVD), compared with paracetamol, the first population-wide study from the University of Hong Kong (HKU) has shown.
